Um Caso Clínico de Lepra Multibacilar com Vários Surtos de Eritema Nodoso Leproso
Resumo
A lepra é uma doença granulomatosa crónica com longo período de incubação causada pelo bacilo Mycobacte- -rium leprae que afeta principalmente a pele, mucosas e sistema nervoso periférico. Tem risco de sequelas permanentes e impacto significativo na qualidade de vida do paciente. É clinicamente heterogénea com possíveis apresentações atípicas. Descrevemos o caso de uma mulher de 31 anos, fototipo V, com lepra multibacilar caracterizada por múltiplos surtos de eritema nodoso leproso como manifestação inaugural. A doença foi adquirida num grupo de crianças e adolescentes de uma região endémica de África, evoluiu sem tratamento durante 3 anos, e manifestou-se com algumas características clínicas incomuns e notável envolvimento linfático. Destacamos a importância da colaboração entre centros especializados e parcerias institucionais, a fim de fornecer os recursos de diagnósti-co e os cuidados adequados às populações afetadas.
Downloads
Referências
Cruz RCdS, Bührer-Sékula S, Penna MLF, Penna GO, Talhari S. Leprosy: current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients. Ana Bras Dermatol. 2017;92:761-73. doi: 10.1590/abd1806-4841.20176724.
Forbes BA, Hall GS, Miller MB, Novak SM, Rowlinson MC, Salfinger M, et al. Practice guidelines for clinical microbiology laboratories: mycobacteria. Clin Microbiol Rev. 2018;31:e00038-17. doi: 10.1128/
CMR.00038-17.
Sarkar R, Pradhan S. Leprosy and women. Int J Womens Dermatol. 2016;2:117-21.
Ridley D, Jopling W. Classification of leprosy according to immunity. A five-group system. Int J Lepr.
;34:255-73.
World Health Organization. WHO expert committee on leprosy. Geneva: WHO expert committee on leprosy; 1998.
World Health Organization. Guidelines for the diagnosis, treatment and prevention of leprosy. Geneva: WHO; 2018.
Kumar SA, Ranjana S, Savitri S, Sanjiv G. How accurately do clinical diagnosis correlate with biopsy findings in leprosy? J Pak Assoc Dermatol. 2017;27):23-9.
de Sousa JR, Sotto MN, Simões Quaresma JA. Leprosy as a complex infection: breakdown of the Th1 and Th2 immune paradigm in the immunopathogenesis of the disease. Front Immunol. 2017;8:1635. doi: 10.3389/fimmu.2017.01635.
Smith CS, Aerts A, Saunderson P, Kawuma J, Kita E, Virmond M. Multidrug therapy for leprosy: a
game changer on the path to elimination. Lancet Infec Dis. 2017;17:e293-7. doi: 10.1016/S1473-3099(17)30418-8.
Chaptini C, Marshman G. Leprosy: a review on elimination, reducing the disease burden, and future research. Lepr Rev. 2015;86:307-15.
Martinez AN, Talhari C, Moraes MO, Talhari S. PCR-based techniques for leprosy diagnosis: from the laboratory to the clinic. PLoS Negl Trop Dis. 2014;8:e2655. doi: 10.1371/journal.pntd.0002655.
Chaitanya V, Cuello L, Das M, Sudharsan A, Ganesan P, Kanmani K, et al. Analysis of a novel multiplex polymerase chain reaction assay as a sensitive tool for the diagnosis of indeterminate and tuberculoid forms of leprosy. Int J Mycobacteriol. 2017;6:1-8. doi: 10.4103/2212-5531.201885.
Franco-Paredes C, Marcos LA, Henao-Martínez AF, Rodríguez-Morales AJ, Villamil-Gómez WE, Gotuzzo E, et al. Cutaneous mycobacterial infections. Clin Microbiol Rev. 2019;32:e00069-18. doi: 10.1128/CMR.00069-18.
Chowdhury AR, Bandyopadhyay G, Bhattacharyya P, Chakraborty S. An unusual presentation of leprosy: Lepromatous lymphadenitis. Int J Med Public Health. 2015;5:381-3. doi: 10.1159/000462959.
Singh P, Mushtaq D, Bala J, Kapur K, Rana A. Lepropmatous lymphadenitis mimicking non hodgkins
lymphoma: A case diagnosed by fine needle aspiration cytology. J Clin Diagn Res. 2011;5:869-71. doi:
1080/10428190410001655166.
Yang SY, Leong WM, Kasunuran CM, Huang JX, Ho SJ, Aw CW, et al. Extensive Lepromatous lymphadenitis preceding lesions on the face and earlobes: an unusual presentation of leprosy in Singapore. Case Rep Dermatol. 2018;10:35-40. doi: 10.1159/000462959.
Nigam P, Kumar P, Pathak N, Mittal S. Fine needle aspiration cytology in reactional and non-reactional leprosy. Indian J Dermatol Venereol Leprol. 2007;73:247.
Rajesh NG, Siddaraju N, Muthalagan E, Jain D, Kumari R, Balasubramanian P. Report of a case emphasizing the clinical utility of fine needle aspiration cytology in the diagnosis of histoid leprosy. Cytopathology. 2015;26:132-3. doi: 10.1111/cyt.12144.
Ray R, Mondal RK, Pathak S. Benefits and limitations of fine needle aspiration cytology in the diagnosis and classification of leprosy in primary and secondary healthcare settings. Cytopathology. 2015;26:238-43. doi: 10.1111/cyt.12179.
Semwal S, Joshi D, Goel G, Asati D, Kapoor N. Clinico-histological correlation in Hansen's disease: three-year experience at a newly established tertiary care center in Central India. Indian J Dermatol. 2018;63:465-8. doi: 10.4103/ijd.IJD_525_17.
Suryawati N, Saputra H. Erythema nodosum leprosum presenting as sweet's syndrome-like reaction in a borderline lepromatous leprosy patient. Int J Mycobacteriol. 2018;7:191-4. doi: 10.4103/ijmy.ijmy_49_18.
Costa PdSS, Fraga LR, Kowalski TW, Daxbacher ELR, Schuler-Faccini L, Vianna FSL. Erythema nodosum leprosum: Update and challenges on the treatment of a neglected condition. Acta Trop. 2018;183:134-41. doi: 10.1111/ddg.13301.
Fischer M. Leprosy–an overview of clinical features, diagnosis, and treatment. J Dtsch Dermatol Ges.
;15:801-27.
Saunderson PR. Uniform multidrug therapy for leprosy – time for a rethink? Indian J Med Res. 2016;144:499-501. doi: 10.4103/0971-5916.200884.
Pocaterra L, Jain S, Reddy R, Muzaffarullah S, Torres O, Suneetha S, et al. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India. Am J Trop Med Hyg. 2006;74:868-79.
Balagon M, Saunderson PR, Gelber RH. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT. Lepr Rev. 2011;82:213-22.
Todos os artigos desta revista são de acesso aberto sob a licença internacional Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0).
